Literature DB >> 2112188

High-frequency oscillatory ventilation compared with conventional mechanical ventilation in the treatment of respiratory failure in preterm infants: assessment of pulmonary function at 9 months of corrected age. HiFi Study Group.

.   

Abstract

In a comparison of the outcome of high-frequency oscillatory ventilation (HFO) and conventional mechanical ventilation (intermittent mandatory ventilation (IMV] in newborn infants, the degree of late pulmonary damage in these infants was assessed in a multicenter trial by examining their pulmonary status, including pulmonary function test results at 9 months of corrected age. A total of 432 infants were followed, 222 in the IMV group and 210 in the HFO group. Two-hundred twenty-three infants had their pulmonary mechanics measured, 118 in the IMV group and 105 in the HFO group. There were no significant differences between the two groups in conditions known to predispose infants to chronic lung disease. At 9 months of age, both groups has similar growth and a similar incidence of respiratory tract infections and hospital readmissions, and of retractions and episodes of wheezing. None of the pulmonary mechanics measurements differed. Forced expiratory flow at functional residual capacity was decreased (132 +/- 86 vs 135 +/- 92 ml/sec in the IMV and HFO groups, respectively), peak-to-peak esophageal pressure change was elevated (14.4 +/- 5.7 vs 13.5 +/- 5.7 cm H2O), dynamic compliance was in the low normal range (1.2 +/- 0.5 vs 1.3 +/- 0.6 ml/cm H2O/kg), and total pulmonary resistance was elevated (63 +/- 43 vs 57 +/- 34 cm H2O/L/sec) when the measurements were compared with normal values. The results indicate that in both groups, 30% to 40% of infants survived with chronic pulmonary changes similar to those described in infants with bronchopulmonary dysplasia. The use of high-frequency ventilation, in comparison with IMV, did not improve long-term pulmonary outcome.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2112188     DOI: 10.1016/s0022-3476(05)80657-2

Source DB:  PubMed          Journal:  J Pediatr        ISSN: 0022-3476            Impact factor:   4.406


  7 in total

1.  Early use of high frequency ventilation in the premature neonate.

Authors:  Patrick Van Reempts; Christel Borstlap; Sabine Laroche; Jean-Claude Van der Auwera
Journal:  Eur J Pediatr       Date:  2003-02-04       Impact factor: 3.183

2.  Randomised trial of high frequency oscillatory ventilation or conventional ventilation in babies of gestational age 28 weeks or less: respiratory and neurological outcomes at 2 years.

Authors:  N Marlow; A Greenough; J L Peacock; L Marston; E S Limb; A H Johnson; S A Calvert
Journal:  Arch Dis Child Fetal Neonatal Ed       Date:  2006-05-11       Impact factor: 5.747

3.  Longitudinal changes in lung function in very prematurely born young people receiving high-frequency oscillation or conventional ventilation from birth.

Authors:  Alessandra Bisquera; Christopher Harris; Alan Lunt; Sanja Zivanovic; Neil Marlow; Sandy Calvert; Anne Greenough; Janet L Peacock
Journal:  Pediatr Pulmonol       Date:  2022-04-18

4.  Scoring method for early prediction of neonatal chronic lung disease using modified respiratory parameters.

Authors:  Young Don Kim; Ellen Ai-Rhan Kim; Ki Soo Kim; Soo Young Pi; Weechang Kang
Journal:  J Korean Med Sci       Date:  2005-06       Impact factor: 2.153

5.  Cardiopulmonary function in premature infants with bronchopulmonary dysplasia--a 2-year follow up.

Authors:  T Farstad; F Brockmeier; D Bratlid
Journal:  Eur J Pediatr       Date:  1995-10       Impact factor: 3.183

Review 6.  Mechanical Ventilation in Pediatric and Neonatal Patients.

Authors:  Michaela Kollisch-Singule; Harry Ramcharran; Joshua Satalin; Sarah Blair; Louis A Gatto; Penny L Andrews; Nader M Habashi; Gary F Nieman; Adel Bougatef
Journal:  Front Physiol       Date:  2022-03-17       Impact factor: 4.566

7.  Late outcomes of a randomized trial of high-frequency oscillation in neonates.

Authors:  Sanja Zivanovic; Janet Peacock; Mireia Alcazar-Paris; Jessica W Lo; Alan Lunt; Neil Marlow; Sandy Calvert; Anne Greenough
Journal:  N Engl J Med       Date:  2014-03-20       Impact factor: 91.245

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.